| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WVE | Ordinary Shares | Purchase | $22,335,440 | +2,791,930 | +20% | $8.00 | 16,775,691 | 27 Sep 2024 | By Corporation | F1 |
| Id | Content |
|---|---|
| F1 | The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person"). |